joining the club

TMC approves the addition of the University of Houston's new medical school

UH's College of Medicine is the newest addition to the Texas Medical Center. Photo courtesy of University of Houston

The largest medical city in the world has a new resident. The University of Houston College of Medicine is the newest official member of the Texas Medical Center (TMC). The move comes following approval by the TMC board of directors, UH announced.

This addition, which is Houston's first new medical school in nearly 50 years, means potential collaboration with dozens of hospitals and academic institutions, including four other medical schools.

UH's new College of Medicine was found to specifically serve underserved communities in Houston and across Texas. To address a critical statewide shortage of primary care doctors, the UH College of Medicine emphasizes primary care, especially in urban and rural communities, which often have poorer health outcomes, a press release notes. The inaugural class launched in fall 2020 with some 30 medical students.

TMC named the University of Houston a member institution in 2009; the school's College of Pharmacy has been a member since 1980.

A new three-story, 130,000-square-foot College of Medicine building is currently under construction on the UH campus, with a summer 2022 opening date. The facility will be located on 43-acres and will feature modern classroom and meeting spaces, state-of-the-art anatomy and simulation suites, and more, per UH.

Unofficially dubbed "Medical City," the Medical Center sees more than 10 million patients per year, employs more than 106,000 total workers, and is home to the world's largest children's hospital (Texas Children's Hospital), and cancer hospital (MD Anderson Cancer Center).

"We are elated to join the Texas Medical Center as a member institution and look forward to engaging with colleagues at other institutions to advance clinical issues and best practices, and further joint research endeavors," said Dr. Stephen Spann, founding dean of the UH College of Medicine and new member of the TMC Advisory Board, in a statement. "The tragedy of the COVID-19 pandemic has paradoxically produced an opportunity to address larger issues facing our health care systems, such as health equity. Together with our TMC partners, we can help be part of the solution."

------

This article originally ran on CultureMap.

Trending News

Building Houston

 
 

BUCHA BIO has raised over $1 million to grow its team, build a new headquarters, and accelerate its go-to-market strategy. Image courtesy of BUCHA BIO

A Houston company that has created a plant-based material that can replace unsustainable conventional leathers and plastics has announced the close of its oversubscribed seed funding round.

BUCHA BIO announced it's raised $1.1 million in seed funding. The round included participation from existing partners New Climate Ventures, Lifely VC, and Beni VC, as well as from new partners Prithvi VC, Asymmetry VC, and investors from the Glasswall Syndicate, including Alwyn Capital, as well as Chris Zarou, CEO & Founder of Visionary Music Group and manager of multi-platinum Grammy-nominated rapper, Logic, the startup reports in a news release.

“I’m excited to back BUCHA BIO’s amazing early market traction," Zarou says in the release. "Their next-gen bio-based materials are game-changing, and their goals align with my personal vision for a more sustainable future within the entertainment industry and beyond.”

The company, which relocated its headquarters from New York to Houston in February, was founded by Zimri T. Hinshaw in 2020 and is based out of the East End Makers Hub and Greentown Houston.

BUCHA BIO has created two bio-based materials using bacterial nanocellulose and other plant-based components. The two materials are SHORAI, which can be used as a leather alternative, and HIKARI, a translucent material that is expected to be formally introduced in November.

The fresh funding will help the company to accelerate its move into the marketplace next year by securing co-manufacturers to scale production. Additionally, the company is growing its team and is hiring for a new supply chain lead as well as some technician roles.

Per the release, BUCHA BIO is working on constructing a new headquarters in Houston that will house a materials development laboratory, prototype manufacturing line, and offices.

BUCHA BIO has the potential to impact several industries from fashion and automotive to construction and electronics. According to the Material Innovation Initiative, the alternative materials industry has seen an increased level of interest from investors who have dedicated over $2 billion into the sector since 2015.

“The time for rapid growth for biomaterials is now," says repeat investor Eric Rubenstein, founding managing partner at Houston-based New Climate Ventures, in the release. "BUCHA BIO's team and technical development are advancing hand in hand with the demands of brand partnerships, and we are excited to support them as they capitalize on this global opportunity.”

Trending News